Sucampo Announces Presentation of Results on Lubiprostone in Pediatric Functional Constipation at NASPGHAN 2013
October 10, 2013 20:00 ET
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., Oct. 10, 2013 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Nasdaq:SCMP) ("Sucampo") today announced the presentation of results from a Phase 3, open-label safety and efficacy...